10-K: Quantum Computing Inc. Reports Increased Net Loss in 2024 Amidst Ongoing Development

Quantum Computing Inc.'s 2024 10-K filing reveals a widening net loss despite a slight revenue increase, as the company continues to invest heavily in research and development and its new chip manufacturing facility.

Summary

• Quantum Computing Inc. (QCi) reported a net loss of $68.5 million for the year ended December 31, 2024, a significant increase from the $27.0 million loss in 2023.
• Total revenue increased slightly to $373,000 in 2024 from $358,000 in 2023, driven by a substantial increase in product revenue.
• The company is focused on developing quantum and ancillary non-quantum products for high-performance computing applications.
• Operating expenses remained relatively stable at approximately $26.0 million, with an increase in research and development expenses offset by a decrease in general and administrative expenses.
• The company is pursuing opportunities under the CHIPS Act to secure funding for its semiconductor research, development, manufacturing, and workforce development.
• QCi is involved in several legal proceedings, including an appraisal action, a breach of contract lawsuit, an injunction lawsuit, and a securities class action lawsuit.
• The company had cash and cash equivalents of $78.9 million as of December 31, 2024, and believes this, along with potential future financing, will be sufficient to meet its liquidity needs for at least the next 12 months.
• The company is implementing measures to remediate material weaknesses in its internal control over financial reporting.
• The company is subject to governmental export and import controls that could impair its ability to compete in international markets.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there's some revenue growth and progress in product development, the significant increase in net loss and ongoing legal challenges weigh negatively. The company's ability to secure future funding and successfully commercialize its technology remains uncertain.

Positives

• Product revenue increased by 440% from 2023 to 2024.
• The company has a strong cash position of $78.9 million as of December 31, 2024.
• QCi is actively pursuing funding opportunities under the CHIPS Act.
• The company is expanding its manufacturing capabilities with the AZ Chips Facility.
• The company has an exclusive license to seven patents issued to the Stevens Institute of Technology.

Negatives

• The company experienced a significant increase in net loss, reaching $68.5 million in 2024.
• The company has a history of operating losses and expects to incur significant expenses and continuing losses for the foreseeable future.
• The company has material weaknesses in its internal control over financial reporting.
• The company is involved in multiple legal proceedings, which could be costly and disruptive.
• The company is subject to governmental export and import controls that could impair its ability to compete in international markets.

Risks

• The company's early-stage status and limited operating history make it difficult to forecast future results.
• The company's business model is unproven and may not allow it to cover its costs.
• The company may not be able to scale its business quickly enough to meet customer and market demand.
• The company will require a significant amount of cash for expenditures and may need additional capital sooner than planned.
• The company's ability to use net operating loss carryforwards may be limited.
• The company faces significant barriers in its attempts to develop and manufacture its products, including the need to invent and develop new technology.
• The quantum computing industry is competitive, and the company may not be successful in competing.
• The company relies on access to high-performance third-party classical computing through public clouds.
• The company depends on certain suppliers to source products, and failure to maintain these relationships could have a material adverse effect.
• The company may become subject to legal proceedings that could have a material adverse impact on its financial position and results of operations.
• The company is subject to governmental export and import controls that could impair its ability to compete in international markets.
• The company may become subject to product liability claims, which could harm its financial condition and liquidity.
• Any failure to obtain, maintain and protect the company's intellectual property rights could impair its ability to protect and commercialize its proprietary products and technology and cause it to lose its competitive advantage.
• The company's stock price has been and may continue to be volatile or may decline regardless of its operating performance, and investors may lose part or all of their investment.
• Future sales of shares of the company's common stock, or the perception in the public markets that these sales may occur, may depress its stock price.
• Delays in filing financial reports, internal control weaknesses, and restatements could hinder the company's ability to regain Form S-3 eligibility and adversely affect its business and stock price.
• Penny stock rules may make buying or selling the company's common stock difficult, which may make its stock less liquid and make it harder for investors to buy and sell its securities.
• Shares of the company's currently issued and outstanding stock may become freely tradable pursuant to Rule 144 and may dilute the market for your shares and have a depressive effect on the price of the shares of its common stock.
• The company currently does not intend to pay dividends on its common stock.
• Investors may experience dilution of their ownership interest due to the future issuance of additional shares of the company's common stock.
• The company's executive officers and directors possess significant voting power with respect to its common stock, which will limit investors' influence on corporate matters.
• The company's articles of incorporation grant the Board the power to issue additional shares of common and preferred shares and to designate other classes of preferred shares, all without stockholder approval.

Future Outlook

The company expects to incur additional losses and higher operating expenses for the foreseeable future as it continues to invest in research and development and go-to-market programs. The company believes that its existing cash and cash equivalents, together with any cash generated from operations and the proceeds from any additional equity or debt issuances will be sufficient to meet the company's liquidity needs for at least the next 12 months.

Industry Context

The document notes a growing demand for computational performance, particularly with the rise of AI and machine learning, and positions quantum computing as a potential solution to the limitations of classical computers. It also acknowledges the competitive landscape with numerous companies and research organizations investing in quantum technology.

Comparison to Industry Standards

• The document references market reports from Grand View Research and Allied Market Research, providing estimates for the high-performance computing and quantum computing markets.
• It mentions competitors like IBM, Google, Intel, Microsoft, Quantinuum, D-Wave Quantum, Rigetti Computing, and IonQ, highlighting the competitive nature of the industry.
• The document cites a Market Research Reports study indicating significant potential market growth for TFLN devices, with the global TFLN electro-optical modulator market expected to grow at a compound annual growth rate of 39 percent.
• It also references a Mordor Intelligence market report forecasting that the photonic integrated circuit (PIC) market will grow at a compound annual growth rate of 20.5% to $38.4 billion in 2029.

Management Changes

Legal Proceedings

• BV Advisory v. QCi Appraisal Action: BV Advisory filed a petition in the Delaware Chancery Court seeking appraisal rights on the shares of common stock of QPhoton it allegedly owns.
• BV Advisory v. QCi Breach of Contract Lawsuit: BV Advisory filed a complaint in the Delaware Superior Court, asserting a claim for breach of the BV Note Purchase Agreement and for breach of the implied covenant of good faith and fair dealing.
• QCi v. BV Advisory Injunction Lawsuit: The Company filed a complaint in Delaware Chancery Court against BV Advisory and its principal Keith Barksdale asserting claims for defamation, breach of contract, conversion, aiding and abetting conversion, and misappropriation of trade secrets.
• Securities Class Action Lawsuit: A class action lawsuit was filed against the Company and certain of its current and past officers in the United States District Court for the District of New Jersey, alleging violations of Section 10(b) and 20(a) of the Exchange Act.
• Arbitration over Stock Options: The Company entered into arbitrations with two former consultants regarding forfeiture of stock options.

Stakeholder Impact

• Shareholders: Dilution from stock issuances, potential for increased value if the company successfully commercializes its technology, risk of loss due to stock price volatility.
• Employees: Potential for job growth and career advancement, risk of job loss due to financial instability.
• Customers: Access to innovative quantum computing solutions, potential for improved business outcomes.
• Suppliers: Opportunity to grow their business with QCi, risk of payment delays or contract termination.
• Creditors: Risk of default on debt obligations, potential for increased returns if the company is successful.

Next Steps

• Continue to invest in research and development and go-to-market programs.
• Pursue opportunities under the CHIPS Act.
• Defend against ongoing legal proceedings.
• Remediate material weaknesses in internal control over financial reporting.

Key Dates

Keywords

quantum computing, photonics, TFLN, high-performance computing, research and development, financial results, risk factors, legal proceedings, internal control, capital stock